Navigation Links
Growth attenuation


Growth attenuation is an elective medical treatment which involves administering estrogen to cause closure of the epiphyses of the bones, resulting in a reduced adult height. Since the 1960s this treatment has been performed primarily on children growing toward an adult height considered unacceptably excessive by their parents and doctors. The cultural consensus of what is considered an excessive height justifying treatment has differed in Europe and North America and has risen over the last 4 decades.[1].

Most of the children treated have been girls, with larger numbers treated in Europe than in North America. The height considered unacceptable by parents and doctors has become substantially taller over the last few decades. Very few boys have ever been treated for excessive tallness in North America.

More recently, growth attenuation treatment has been in the news as part of the controversial Ashley Treatment administered to a developmentally disabled girl.

References

  1. ^ Joyce M. Lee and Joel D. Howell.Tall Girls: The Social Shaping of a Medical Therapy Archives of Pediatrics & Adolescent Medicine, Vol. 160 No. 10, October 2006.



'"/>


(Date:1/14/2019)... ... ... Reviewed & Approved Living Well Providers of 2019. , Acupuncture, Dr. Wai ... - Maplewood , Dr. Joanna Jodar - Somerset , Dr. Barbara Knoll - ... Pleasant , Dr. Robert J. Reinhardt - Pequannock , Dr. Sylvester Rich - ...
(Date:1/13/2019)... , ... , ... to present the following recently reviewed and approved providers for December 2018. , IL Top Docs Include: , ... Dr. Barbara Amsler , Dr. Naresh Chandan , Dr. Marcie Claybon ... Dr. Amarish Dave , OBGYN, Dr. ...
(Date:1/11/2019)... ... 11, 2019 , ... Women’s Excellence Obstetrics and Gynecology announces ... Zaidan, President of Women’s Excellence, will co-host WJR’s "Health Women Show" with WJR’s ... at 7pm. , "We are excited to partner with a longstanding, reputable organization ...
(Date:1/10/2019)... Texas (PRWEB) , ... January 10, 2019 , ... The ... “Zac” Jiwa as its new President & Chief Executive Officer effective immediately. Mr. ... in December after 9 years of service. The transition was announced as part ...
(Date:1/8/2019)... ... January 08, 2019 , ... ... that they now have Norepinephrine in their patent-pending vial-based configuration, Snap-N-Go®, available ... concentrations that are not commercially available) deliver a precise dose when introduced ...
Breaking Medicine News(10 mins):
Other medicine definition